The future of medicine is based on intensive research. Innovations from genetic research and digitization, for example, are revolutionizing medicine and healthcare more than ever before. Strong entrepreneurs are also needed to turn scientists‘ results into real products and help to improve patients’ diagnosis, prevention, therapy, nursing and rehabilitation. These stories provide insights into the top research and development in central Hessen and show the latest trends – always for the benefit of patients all over the world.
Why is donating blood plasma so important? Plasma serves as a raw material for the production of life-saving drugs. To ensure the production of these therapeutics, plasma donors are urgently needed – especially, now, during the pandemic.
At the Center for Unknown and Rare Diseases (ZusE) at Marburg University Hospital, patients find help from Prof. Juergen Schaefer.
DFG President Prof. Dr. Katja Becker has dedicated her life as a researcher to one goal in particular: to develop new drugs and diagnostics against poverty-associated and neglected infectious diseases.
In the search for medicines to treat COVID-19, lung researchers from Giessen are testing an existing active ingredient that has already been proven to prevent lung damage.
Insect research is a Giessen success story: Experts expect innovative solutions for global challenges. The State of Hessen is now providing further funding for the region’s scientific efforts.
The new MacTRAP mouse line allows researchers to closely study ‘hidden’ renal macrophages. These results open up new possibilities for the diagnosis of inflammatory diseases.
Die Deutsche Forschungsgemeinschaft (DFG) unterstützt mit 13,84 Millionen Euro ein Forschungskonsortium aus Mittelhessen, das nach neuen Strategien zur Behandlung von tödlichen und bislang unheilbaren Lungenhochdruck sucht.
Marburg-based pharmaceutical company CSL Behring is conducting intensive research on a suitable active substance against Covid-19 with the use of donated blood plasma. A globally active „Plasma Alliance“ established for this purpose supports the company’s goals.